Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
Sign Up to like & getrecommendations! Published in 2017 at "Science Advances"
DOI: 10.1126/sciadv.1602133
Abstract: Cooperative therapeutic effect of anti-CTLA4 and anti-sMIC antibodies. Antibody therapy targeting cytotoxic T lymphocyte–associated antigen 4 (CTLA4) elicited survival benefits in cancer patients; however, the overall response rate is limited. In addition, anti-CTLA4 antibody therapy… read more here.
Keywords: antibody therapy; anti ctla4; antibody; ctla4 antibody ... See more keywords